Senseonics Holdings (SENS) Research & Development (2015 - 2026)
Senseonics Holdings (SENS) posted quarterly Research & Development of $8.6 million for Q1 2026, up 17.98% year-over-year from $7.3 million in Q1 2025, and down 2.36% quarter-over-quarter from $8.8 million in Q4 2025.
Senseonics Holdings (SENS) Research & Development (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Research & Development for 12 consecutive years, with $8.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 17.98% year-over-year to $8.6 million; the TTM figure through Mar 2026 stood at $32.9 million (down 13.42% YoY), while the FY2025 annual figure was $31.6 million, down 23.22% from the prior year.
- Research & Development retreated to $8.6 million in Q1 2026 per SENS's latest filing, from $8.8 million in the prior quarter.
- Across five years, Research & Development topped out at $12.8 million in Q2 2023 and bottomed at -$37.7 million in Q4 2023.
- Historically, Research & Development has averaged $7.1 million across 5 years, with a median of $9.4 million in 2024.
- Annual changes were most pronounced in 2023 — Research & Development slumped 424.16% — and 2024, when it surged 124.83%.
- Senseonics Holdings' Research & Development stood at $11.6 million in 2022, then plunged by 424.16% to -$37.7 million in 2023, then surged by 124.83% to $9.4 million in 2024, then slipped by 5.78% to $8.8 million in 2025, then slipped by 2.36% to $8.6 million in 2026.
- Business Quant data shows SENS's Research & Development at $8.6 million in Q1 2026, $8.8 million in Q4 2025, and $7.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Senseonics Holdings | 524.34 Mn | 283.74 Mn | 8.56 Mn | 11.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.64 Mn |
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 8.82 Mn |
| Sep 30, 2025 | 7.76 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 9.36 Mn |
| Sep 30, 2024 | 10.55 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 10.44 Mn |
| Dec 31, 2023 | -37.70 Mn |
| Sep 30, 2023 | 12.77 Mn |
| Jun 30, 2023 | 12.83 Mn |
| Mar 31, 2023 | 12.41 Mn |
| Dec 31, 2022 | 11.63 Mn |
| Sep 30, 2022 | 10.99 Mn |
| Jun 30, 2022 | 9.30 Mn |
| Mar 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 7.20 Mn |